• Fleshner N, Gomella LG et al for the REDEEM Study Group. Delay in the progression of low-risk prostate cáncer: Rationale and design of the reduction by dutasteride of clinical progression events in expectant management (REDEEM) trial. Cont Clin Trials. 2007 May 29
• Fleshner N, Bagnell P et al. Dietary fat and prostate cáncer. J Urol 171(2) part 2 of 2: S19-S24, Feb 2004.
• Fleshner N, Klotz L, Sugar L et al. Evidence for benefit of combination antioxidant therapy: Results of a randomized Phase II preoperative intervention study. Abstract # 651, J Urol 177(4):219, April 2007
• Foley S, Bailey D. Microvessel density in prostatic hyperplasía. BJU International 85: 70–73,2000
• Fotsis T. Genistein a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 125 (3 Suppl): 790S-797S,1995
• Freedland S, Grubb K, Sindy K, et al. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center. J Urol 174(3):919-922, Sept 2005
• Fraser D. Exploration of possible mechanisms linking vitamin D status and dietary calcium to prostate cáncer. Br J Nutr. 97(4):596-597, april 2007
• Freedland S, Aronson W. Obesity and prostate cáncer. Urology 65(3):433-439,March 2005.
• Fullerton S, Samadi A, Tortorelis D, et al. Induction of Apoptosis in Human Prostatic Cáncer cells with beta-Glucan (Maitake Mushroom polysaccharide) Molecular Urology 4(1) :7-13,2000
• Gann P, Ma J, Giovannucci E. Lower prostate cáncer risk in men with elevated plasma lycopene levels: Results of a prospective analysis. Cáncer Res 59:1225-1230,1999
• Gann P. The risk of Disease. Prostate cáncer progression risk reduction and future options. Symposium Chairman Eric Klein Cleveland Clinic Foundation May Orlando 2002.
• Gao S, Liu G, Wang Z. Modulation of androgen receptor-dependant transcription by resveratrol and genistein in prostate cáncer cells. Prostate 59(2): 214-225, 2004
• Gardner-Thorpe D, O'Hagen C, Young I, Lewis S. Dietary supplements of soy flour lower serum testosterone concentrations and improve markers of oxidative stress in men. European Journal Clin Nutr 57(1):100-106, Jan 2003
• Garraway W. High prevalence of benign prostatic hypertrophy in the community. Lancet 338/469-471, 1991
• Garrison J, Kyprianou N. Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway. Cáncer Research 66(1):464-472, 1 Jan 2006
• Gaziano J, Manson J, Branch L, et al. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol 5:255-260, 1995
• Gdor Y, Kadmon D. Nutritional approaches to prostate cáncer prevention. Cont Urology 14(8);54-67, Aug 2002
• Gerber G, Kuznetsov D, Johnson B et al. Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms.Urology. 58(6):960-964, Dec 2001
• Gerster H. The potential role of lycopene for human health. J Am College of Nutrition 16(2):109-126,1997
• Gerstenbluth R, Seftel A, MacLennan G, et al. Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation. J Urol 167:2267,2002.
• Gerber G, Kutnesov D et al. Randomized double-blind, placebo-controlled trial of Saw Palmetto in men with LUTS. Urology 2001;58:960-964
• Getzenberg R et al. Vitamin D inhibition of prostate adenocarcinoma growth and metastasís in the Dunning rat prostate model system. Urology 50:999-1006, 1997.
• Ghen M, Corso N. Macronutrients: 566-575. Complem & Alternative Medicine. Novey DW. Mosby 2000.
• Ghosh J, Myers C. Inhibition of arachidonate 5-lipoxygenase triggers mássive apoptosis in human prostate cáncer cells. Medical Sciences 95(22):13182-13187, Oct 1998
• Gillespie S. Herbal drugs and phytomedicinal agents. Pharm Times 63(12):53-61,1997
• Gillman M. Enjoy your fruits and vegetables (editorials). BMJ 313:765-766 Sept 1996
• Gillman M et al. Protective effect of fruits and vegetables on development of stroke in men. JAMA 273:1113-1117, 1995
• Giovannucci E. Tomatoes, Tomato-Based Products, Lycopene, and Cáncer: Review of the Epidemiologic Literature. Journal of the National Cáncer Institute 91 (4): 317-331, Feb 17 1999
• Giovannucci E, Leitzmann M, Spiegelman D, et al. A prospective study of physical activity and prostate cáncer in male health professionals. Cáncer Res. 58(22):5117-5122, 15 Nov 1998
• Giovannucci E. Calcium and milk and Prostate cáncer: A review of the evidence. Prostate Journal 1(1):1-7, Jan-Feb 1999
• Giovannucci E, Rimm E et al. A prospective study of dietary fat and risk of prostate cáncer. J Natl Cáncer Inst 1993 Oct 85:1571-9
• Giovannucci E, Rimm E, Liu Y et al. A prospective study of cruciferous vegetables and prostate cáncer. Cáncer Epidemiol Biomarkers Prev. 12(12):1403-1409, Dec 2003
• Giovannucci E, Ascherio A et al. Intake of carotenoids and retinol in relation to risk of prostate cáncer. J Natl Cáncer Inst 87(23):1767-1776, Dec 1995
• Giovannucci E. Rimm E, Wolk A et al. Calcium and fructose intake in relation to risk of prostate cáncer. Cáncer Research 58(3):442-7, Feb 1998
• Giovannucci E, Rimm E, Ascherio A. Smoking and risk of total and fatal prostate cáncer in United States Health professionals. Cáncer Epidemiol Biomark Prev 8:277-282,1999
• Giovanucci E, Platz E. Nutritional and environmental epidemiology of prostate cáncer. Chap 8 -117-139. In Prostate Cáncer Principles & Practice. Kantoff, Carroll, D Amico. Lippincott Williams & Wilkins, 2002
• Glanz K et al. Stages of change in adopting healthy diets: fat, fiber, and correlates of nutrient intake. Health Education Quaterly 21:499-519, 1994
• Gleave M, Qian J, Andreou C et al.The effects of the dual 5alpha-reductase inhibitor dutasteride on localized prostate cáncer--results from a 4-month pre-radical prostatectomy study. Prostate. 66(15):1674-1685, 1 Nov 2006
• Glemain P, Coulange C, Grapin F et al. What is the benefit of combining tamsulosin with serenoa repens versus tamsulosin alone on storage/filling and voiding Lower Urinary Tract Symptoms (LUTS)? European Urology Supplements, 1(1):108, Jan 2002.
• Glemain P, Coulange C, Billebaud T, et al. Groupe de l'essai OCOS. Tamsulosin with or without Serenoa repens in benign prostatic hyperplasía: the OCOS trial. Prog Urol. 12(3):395-403, Jun 2002
• Goldenberg S et al. The value of symptom score, quality of life score, maximal urinary flow rate, residual volume and prostate size for the diagnosis of obstructive benign prostatic hyperplasía: a urodynamic analysis - Editorial Comment Journal Urol 157: 2267, 1997
• Goldmann W et al. Saw palmetto berry extract inhibits cell growth and Cox-2 expression in prostatic cáncer cells. Cell Biol Int 25:1117-24, 2001
• Goodman G et al. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cáncer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cáncer Inst. 96(23):1743-1750, 1 Dec 2004
• Gomella L. Chemoprevention using dutasteride: the REDUCE trial. Curr Opin Urol. Jan;15(1):29-32, 2005
• Gorelick J, Senterfit L, Vaughan E. Quantitative bacterial tissue cultures from 209 prostatectomy specimens: findings and implications. J Urol. 139:57-60, 1988
• Gossell-Williams M, Davis A, O'Connor N. Inhibition of testosterone-induced hyperplasía of the prostate of sprague-dawley rats by pumpkin seed oil. J Med Food. 9(2):284-286, Summer 2006
• Gramenzi A et al. Association between certain foods and risk of acute myocardial infarction in women. BMJ 300:771-773, 1990
• Greer S, Morris T et al. Psychological response to breast cáncer: effect on outcome. Lancet 2(8):785-787,1979
• Greenberg E, Sporn M. Antioxidant vitamins, cáncer, and cardiovascular disease. N Engl J Med 334:1189-1190, 1996
• Griffiths K et al. Possible relationship between dietary factors and pathogenesis of prostate cáncer. Int J Urol 5(3):195-213, 1998.
• Griffiths K et al. Phytoestrogens and diseases of the prostate gland. Baillieres Clin Endocrinol Metab. 12(4):625-647, Dec 1998
• Gronberg H, Isaacs S, Smith J. Characteristics of prostate cáncer in families potentially linked to the hereditary prostate cáncer 1 (HPC1) locus. JAMA Journal American Medical Association 278(15): 1251-1255, 1997.
• Gronberg H. Prostate cáncer epidemiology. Lancet 361: 859-864,2003
• Grossfeld G. Angiogenesis Inhibitors show promise for treatment of genitourinary malignancies. AUA News,1(4),Nov/Dec 1996
• Gupta S, Ahmad N, Mukhtar H. Prostate cáncer chemoprevention by green tea. Semin Oncol 17(2):70-76, May 1999
• Gupta S, Ahmad N, Mohan R et al. Prostate cáncer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Cáncer Res. 59(9):2115-2120, 1 May 1999
• Gupta S, Srivastava M, Ahmad N. Lipooxygenasa-5 is overexpressed in prostate adenocarcinoma. Cáncer 91 (4):737-743, 2001
• Gurley B et al. Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm 57:963-969, 2000
• Habib F et al Identification of a prostate inhibitory substance in a pollen extract. Prostate. 26(3):133-139, Mar 1995
• Habib F et al. In vitro evaluation of the pollen extract cernitin T-60 in the regulation of prostate cell growth. Br J Urol 66(4):393-97, Oct 1990
• Habito R, Montalto J, Leslie E. Effects of replacing meat with soybean in the diet on sex hormone concentration in healthy adult males. Br J Nutr 84 (4):557-563, 2000
• Halicka H et al. Apoptosis and cell cycle effects inducted by extracts of the chinese herbal preparation PC-SPES. Int J Oncol 11:437,1999.
• Han H, Shan S, Zhang X. Down-regulation of prostate specific antigen in LNCaP cells by flavonoids from the pollen of Brassica napus L. Phytomedicine. 14(5):338-343, May 2007
• Haenszel W, Kurihara M. Studies of Japanese migrants, I: mortality from cáncer and other disease among Japanese in United States. Journal of the National Cáncer Institute 40(1): 43-68, Jan 1968.
• Hamalainen E et al. Diet and serum sex hormones in healthy men. Journal of Steroid Biochemistry 20(1): 459-464, 1984.
• Hartman T et al. Association between serum alpha-tocopherol and serum androgens and estrogens in older men. Nutr Cáncer 35:10-15, 1999
• Hartman T, Albanes D, Pietinen P et al. The association between baseline vitamin E, Selenium and prostate cáncer in the alpha-tocopherol, beta-carotene cáncer prevention study. Cáncer Epidemiology. Biomarkers & Prevention 7:335-340, 1998
• Hartmann R, Mark M, Soldati F. Inhibition of 5 alpha-reductase and aromatase by PHL-00801, a combination of PY 102 (Pygeum africanum) and UR 102 (Urtica dioica) extracts. Phytomedicine. 1996;3:121–128.
• Harras A, Edwards B, Blot W, eds. Cáncer Rates and Risks. Cáncer incidence in the United States (SEER) age-specific rates. 4th ed., Bethesda, Md: National Cáncer Institute, 1996, pp 22
• Havsteen B. The biochemistry and medical significance of the flavonoids. Pharmacology and Therapeutics, 96(2-3):67-202,2002